Results 121 to 130 of about 45,546 (194)

Outcomes From the Multicenter ACCRU-LY-1804/CARiBOU TRIAL (Cytarabine, Acalabrutinib and Rituximab Integrated With Bortezomib-Based Outpatient Therapy) in 1st Line Mantle Cell Lymphoma. [PDF]

Am J Hematol
Smith SD, Sundaram S, Giri S, Ness A, Wang Y, Gopal AK, Pang Y, Tatoian ET, Grossfeld T, Lynch RC, Warren EH, Nowakowski GS, Park SI.   +12 more
europepmc   +1 more source

Venetoclax in combination with cytarabine with or without idarubicin or azacitidine in children, adolescents, and young adults with relapsed or refractory acute myeloid leukaemia (VENAML): a multicentre, phase 1 expansion study. [PDF]

Lancet Haematol
Daniels KP, Pounds SB, Wu H, Wang L, Alexander TB, Budhraja A, Wolf J, Westover T, Mead PE, Mehr CM, Gupta SD, Lacayo NJ, Inaba H, Rees M, Pui CH, Opferman JT, Klco JM, Rubnitz JE, Karol SE.   +18 more
europepmc   +1 more source

Myelopathy following intrathecal chemotherapy in a patient with acute lymphoblastic leukemia: a case report. [PDF]

Front Oncol
Li J, Mao X, Yu F, Huang Y, Wang Y, Li J, Li L, Wang B.   +7 more
europepmc   +1 more source

Case Report: Successful treatment of mixed-phenotype acute leukemia with cauda equina syndrome as the initial manifestation. [PDF]

Front Oncol
Xu X, Zhang P, Zhang J, Zheng L, Wang Y, Wang P, Ding Y, Tan Y, Xu S, Wei L.   +9 more
europepmc   +1 more source

Central nervous system recurrence of diffuse large B-cell lymphoma - risk stratification and prophylaxis. [PDF]

Hematol Transfus Cell Ther
Soares TS, Ribeiro DD.
europepmc   +1 more source

CBFB-MYH11 directly activates TGFβ and PD-L1 to drive immune evasion in acute myeloid leukemia. [PDF]

J Immunother Cancer
Fang H, Liu C, Lu X, Zhang T, Fang X, Mori SF, Yu M, Han Q, Ruby Y, Wang G, Peters D, Zhang L, Shi H, Liu K, Cortes J, Ding H, Liu P, Cheng B, Hu T.   +18 more
europepmc   +1 more source

Intensified Rituximab, Methotrexate, Procarbazine, and Cytarabine (R-MPVA) Regimen With Sequential Addition of Etoposide to R-MPV and Ifosfamide to R-AraC for Newly Diagnosed Primary CNS Lymphoma Patients Aged Between 60 and 70 Years: An LOC Network Study. [PDF]

Hematol Oncol
Antherieu G, Julia E, Lapierre L, Donzel M, Houillier C, Soussain C, Nicolas-Virelizier E, Rey P, Ducray F, Meyronet D, Picart T, Ysebaert L, Hoang Xuan K, Obéric L, Ghesquières H.   +14 more
europepmc   +1 more source

Venetoclax plus Idarubicin and cytarabine as frontline induction for newly diagnosed acute myeloid leukemia in young, fit adults: a real-world study. [PDF]

Ann Hematol
Ma C, Yue N, Hu W, Yang Y, Wu C, Yue L, Zeng P, Chen H.   +7 more
europepmc   +1 more source

Intensive Induction in AML in the Era of Venetoclax: A Standing Count for "7 + 3"? [PDF]

Am J Hematol
Tauro S, Tefferi A.
europepmc   +1 more source

Phlegmonous Gastritis During Consolidation Therapy With High-Dose Cytarabine and FLT3 Inhibitor in FLT3-ITD-Mutated Acute Myeloid Leukemia. [PDF]

Cureus
Itamura H, Mihashi T, Hirano Y, Kimura S.   +3 more
europepmc   +1 more source